Methylmalonate accumulation contributes to myocardial vulnerability post-reperfusion: a novel therapeutic target and

Shanjie Wang1,2, JunChen Guo1,2, Zeng Wang1,2

  • 1Department of Cardiology, Second Affiliated Hospital of Harbin Medical University, Harbin, China.

BMC Medicine
|December 31, 2025
PubMed
Abstract

Insights

Methylmalonic acid (MMA) exacerbates myocardial injury after reperfusion, distinct from succinate. Targeting MMA metabolism may improve risk stratification and reduce heart damage in acute myocardial infarction patients.

Area of Science:

  • Cardiovascular Research
  • Mitochondrial Biology
  • Metabolic Disorders

Background:

  • Mitochondrial dysfunction is key in myocardial ischemia-reperfusion (I/R) injury, yet clinical applications are limited.
  • Methylmalonic acidemia, a metabolic disorder, causes severe mitochondrial damage.
  • The role of methylmalonic acid (MMA) in I/R pathogenesis and its clinical relevance were previously unknown.

Purpose of the Study:

  • To investigate the biological impact of MMA on myocardial I/R injury.
  • To explore the translational relevance of targeting MMA metabolism in I/R.
  • To compare MMA's effect with its isomer, succinate, in I/R.

Main Methods:

  • Measured MMA and metabolites in human cohorts and animal models.
  • Utilized mouse I/R models with endogenous MMA elevation (Mmut-conditional knockout) and exogenous MMA administration.
  • Employed multiomics, ChIP, and mutagenesis assays to elucidate mechanisms; assessed therapeutic potential in a porcine I/R model.

Main Results:

  • Circulating MMA levels predict post-reperfusion myocardial injury and heart failure risk, outperforming succinate in humans.
  • Both MMA and succinate increased in early I/R mouse hearts, but MMA persisted while succinate normalized.
  • MMA, not succinate, heightened I/R susceptibility and mitochondrial dysfunction, inhibiting SIRT1-CREB-BNIP3 signaling for mitochondrial quality control.

Conclusions:

  • MMA has a detrimental effect on myocardial vulnerability, separate from succinate's role.
  • Targeting MMA metabolism offers a potential strategy for risk stratification and mitigating myocardial injury in acute myocardial infarction (AMI).

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
339
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
155
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
235